ecancer

Role of metronomics in cancer clinical trials and practice in developing countries

Prof Shripad Banavali - Tata Memorial Centre, Mumbai, India

19 Jul 2013

ECC 2013 Preview: Scientific programme highlights

Prof Vincenzo Valentini and Ian Banks

11 Jul 2013

Science behind phase I clinical trials: targeting tumour cell development pathways

Dr Gary K. Schwartz - Memorial Sloan-Kettering Cancer Center, New York, USA

6 Jun 2013

Next generation of anti-cancer agents: data from ASCO 2013

Dr Sarah Blagden - Imperial College, London, UK

4 Jun 2013

Biennial cervical cancer screening with vinegar reduces mortality

Dr Surendra Srinivas Shastri - Tata Memorial Hospital Mumbai, India

3 Jun 2013

Biennial cervical cancer screening with vinegar reduces mortality

Dr Surendra Srinivas Shastri - Tata Memorial Hospital Mumbai, India

2 Jun 2013

Comment on biennial visual inspection with acetic acid (VIA), or vinegar

Prof Krishnansu Sujata Tewari - University of California Irvine, Orange, USA

2 Jun 2013

Delayed relapse of advanced ovarian cancer when treating with pazopanib

Dr Andreas du Bois - Kliniken Essen Mitte, Essen, Germany

1 Jun 2013

Spouses of patients with HPV-positive oropharyngeal cancer do not have increased oral HPV infections

Dr Gypsyamber D’Souza - Johns Hopkins Bloomberg School of Public Health, Baltimore, USA

1 Jun 2013

Maintenance therapy with multi-targeted drug pazopanib delays relapse of advanced ovarian cancer

Dr Andreas du Bois - Kliniken Essen Mitte, Germany

1 Jun 2013

Integrating breast cancer genomics and proteomics

Dr Gordon Mills - University of Texas MD Anderson Cancer Center, Houston, USA

15 May 2013

Targeting tumour suppressor genes

Dr Douglas Lowy - National Cancer Institute, Bethesda, USA

19 Apr 2013

More from ecancer